NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We Do
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • OUR 20 RESEARCH THEMES

        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
        • Oxford Biomedical Research Centre activities during COVID-19
  • Patient & Public Involvement
    • Getting involved with research
    • Researcher Guidance
    • Post an opportunity for patient and public involvement
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events
Research Theme

Haematology and Stem Cells

You are here: Home > News listings for Haematology and Stem Cells

News for Haematology and Stem Cells

Three new Blood and Transplant Research Units created in Oxford

18 May 2022 · Listed under Clinical Informatics and Big Data, Genomic Medicine, Haematology and Stem Cells

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford. The £20m programme, co-funded by the National Institute for Health and Care Research (NIHR) and NHS Blood and Transplant (NHSBT), are aimed at providing new technologies, techniques or insights that will benefit donation, transfusion, and transplantation, and that … Read more

Spin-out company Alethiomics launched

17 December 2021 · Listed under Haematology and Stem Cells, Oxford Blood Group

A new Oxford-based drug-discovery company has been launched with the aim of developing targeted therapies for a specific family of blood cancers. Alethiomics was founded by Oxford BRC-supported researchers Professor Adam Mead  and Professor Beth Psaila, with support from Oxford University Innovation. Alethiomics aims to apply innovations in single-cell multi-omic analysis to the development of novel … Read more

New atlas reveals pre-birth development of blood cells in bone marrow

29 September 2021 · Listed under Gastroenterology and Mucosal Immunity, Haematology and Stem Cells, Oxford Blood Group

A new study has provided the most detailed analysis so far of the prenatal development of blood and immune cells in the bone marrow. The study, published in Nature, is part of the Human Cell Atlas (HCA) initiative to provide comprehensive reference maps of every cell type in the human body. The research team include … Read more

Researchers develop algorithm to diagnose deep vein thrombosis

15 September 2021 · Listed under Haematology and Stem Cells, Oxford Blood Group, Technology and Digital Health

Researchers are developing an artificial intelligence (AI) algorithm to diagnose deep vein thrombosis (DVT) more quickly and as effectively as traditional radiologist-interpreted diagnostic scans, potentially cutting down long patient waiting lists and avoiding patients unnecessarily receiving drugs to treat DVT when they don’t have it. The study, published in the journal Digital Medicine, is the … Read more

Study investigates responses to COVID-19 treatment in chronic lymphoid leukaemia patients

27 August 2021 · Listed under COVID-19, Haematology and Stem Cells, Oxford Blood Group

The COVID-19 pandemic has led to understandable anxiety within the blood cancer community about how their illness may affect their ability to overcome COVID-19 infection. Members of the Oxford Centre for Haematology have led a collaborative research project looking at the response of patients with chronic lymphocytic leukaemia (CLL) who were infected with COVID-19. The … Read more

Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers

17 June 2021 · Listed under COVID-19, Haematology and Stem Cells

Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population. While this is expected to improve with the second dose, this important finding may help influence the design of future vaccination strategies, with further … Read more

New trial PROMises hope for patients affected by myelofibrosis

26 May 2021 · Listed under Haematology and Stem Cells

A new clinical trial has been launched to offer a novel treatment option for patients with the blood cancer myelofibrosis (MF). The PROMise trial, launched by the Cure Leukaemia-funded Trials Acceleration Programme, will involve patients aged 16 or over at 15 NHS centres, including Oxford’s Churchill Hospital. Its Chief Investigator is University of Oxford Professor … Read more

What Matters Most: A workshop methodology to hear patients’ priorities

16 April 2021 · Listed under Oxford Blood Group

Oxford researchers meet patients to discuss new Advanced Cellular Therapies Centre

29 January 2021 · Listed under Haematology and Stem Cells, Oxford Blood Group

Oxford researchers have met with members of the Oxford Blood Group to discuss plans for an Advanced Cellular Therapies Centre. Plans for the creation of an Oxford Advanced Cellular Therapies Centre have been supported by NIHR Research Capability Funding. The proposed centre will bring together scientists, state-of-the-art laboratory facilities, and a treatment centre for the … Read more

Eight BRC projects get RCF funding

7 September 2020 · Listed under Cardiovascular, Clinical Informatics and Big Data, Diabetes and Metabolism, Gastroenterology and Mucosal Immunity, Genomic Medicine, Haematology and Stem Cells, Imaging, Molecular Diagnostics, Multi-Modal Cancer Therapies, Multimorbidity and Long-Term Conditions, Neurological Conditions, Stroke and Vascular Dementia, Surgical Innovation and Evaluation, Technology and Digital Health

Eight Oxford BRC proposals, many covering a number of themes, have been awarded NIHR Research Capability Funding (RCF) funding to take forward key areas of research. The selected projects that will be supported include: Developing a research centre devoted to urgent and acute care The creation of a state-of-the-art imaging centre; and of a new … Read more

Test developed to identify new-borns at risk of leukaemia

21 August 2020 · Listed under Haematology and Stem Cells, Molecular Diagnostics

Oxford researchers have developed a new method to quickly identify cancerous cells in babies at risk of leukaemia. The team hope that the new protocol could make rapid testing more accessible for clinical laboratories around the globe. Until now, the only reliable way to know if a baby with Down’s syndrome is at risk of … Read more

Serum iron may be useful biomarker to identify COVID-19 disease severity

15 June 2020 · Listed under COVID-19, Haematology and Stem Cells

A new study led by University of Oxford researchers has found that patients with severe COVID-19 respiratory failure have very low levels of iron, compared to those with less severe disease.  Changes in iron levels have been associated with worsening disease for other viral infections such as HIV and Hepatitis C, but this is the … Read more

BRC funds three further COVID-19 studies

21 April 2020 · Listed under COVID-19, Gastroenterology and Mucosal Immunity, Haematology and Stem Cells, Vaccines for Emerging and Endemic Diseases

Three more studies are being funded by the NIHR Oxford Biomedical Research Centre (BRC) to look at the way the body interacts with COVID19; these include assessing the safety of a new vaccine; the role that antibodies might play in plasma therapy; and blood biomarkers that determine adverse reactions in those that have been infected. … Read more

Seven new Senior Fellows named

2 April 2020 · Listed under Haematology and Stem Cells, Multi-Modal Cancer Therapies, Neurological Conditions, Other News

The Oxford BRC is delighted to announce the appointment of seven new Senior Research Fellows, the second cohort of emerging research leaders to receive the accolade. The selection process was a coordinated effort by the Oxford BRC and its partners in the NIHR Oxford Health BRC, which focuses on mental health and dementia, and the … Read more

Oxford haematologists win national awards to further their research

13 September 2019 · Listed under Cardiovascular, Haematology and Stem Cells

Two consultant haematologists at the Oxford Haemophilia and Thrombosis Centre (OHTC), based at the Churchill Hospital, have been awarded funding for their research as part of a new national scheme. Dr Nicola Curry and Dr Susie Shapiro were among the recipients of the new Clinical Academic Research Partnerships (CARPs), awarded by the Medical Research Council … Read more

Study discovers genetic changes linked to leukaemia in children with Down’s syndrome

11 July 2019 · Listed under Haematology and Stem Cells, Molecular Diagnostics

Researchers at the University of Oxford have discovered the specific gene mutations that are required for the development of leukaemia in children with Down’s syndrome. Children with Down’s syndrome have a 150-fold increased risk of myeloid leukaemia, and while some of the genetic causes of this have been previously established, this is the first study … Read more

Oxford Blood Group: Exchange Newsletter Issue 3 vol 1 / June 2019

9 July 2019 · Listed under Oxford Blood Group

Patient involvement partnership sets priorities for rare inherited anaemias

28 February 2019 · Listed under Haematology and Stem Cells, Oxford Blood Group, Partnerships for Health, Wealth and Innovation, Patient and Public Involvement and Engagement

On the occasion of Rare Diseases Day, marked every year on the last day of February, we are sharing this article about how patients, carers, clinicians and researchers are collaborating to decide key questions to shape future research into rare forms of anaemia. Patients with anaemia lack red blood cells, or haemoglobin, which means that … Read more

Oxford researchers develop new technique to analyse cancer cells’ life history

11 February 2019 · Listed under Haematology and Stem Cells, Molecular Diagnostics

A team of researchers from the University of Oxford has developed a new technique that allows scientists to reliably track genetic errors in individual cancer cells, and find out how these might lead to uncontrollable growth. The research by the MRC Weatherall Institute of Molecular Medicine, supported by the NIHR Oxford Biomedical Research Centre, could … Read more

Oxford Blood Group: Exchange Newsletter Issue 1 vol 2 / Nov 2018

26 November 2018 · Listed under Oxford Blood Group

Oxford Blood Group Exchange issue 1 preview
  • 1
  • 2
  • Next Page »

Haematology and Stem Cells Theme

  • Introduction
  • Our Sub-Themes
    • Blood Cancer and its Treatment
    • Red Cells
    • Transfusion and Controlling Blood Loss and Abnormal Clotting
  • Patient and Public Involvement (PPI) with the Haematology and Stem Cells theme
  • Oxford Blood Group
    • Exchange Newsletters and related news
  • Contacts
  • Videos for this theme
  • News for this theme
  • General News Listings
Oxford Blood Group for Patients

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2022 NIHR Oxford Biomedical Research Centre